pioglitazone has been researched along with Urinary Lithiasis in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z | 1 |
| Yuan, P | 1 |
| Sun, X | 1 |
| Tang, K | 1 |
| Liu, H | 1 |
| Han, S | 1 |
| Ye, T | 1 |
| Liu, X | 1 |
| Yang, X | 1 |
| Zeng, J | 1 |
| Yan, L | 1 |
| Xing, J | 1 |
| Xiao, K | 1 |
| Ye, Z | 1 |
| Xu, H | 1 |
| Yasui, T | 1 |
| Okada, A | 1 |
| Hamamoto, S | 1 |
| Ando, R | 1 |
| Taguchi, K | 1 |
| Tozawa, K | 1 |
| Kohri, K | 1 |
1 review available for pioglitazone and Urinary Lithiasis
| Article | Year |
|---|---|
Pathophysiology-based treatment of urolithiasis.
Topics: Animals; Cardiovascular Diseases; Cholesterol, Dietary; Diabetes Mellitus, Type 2; Disease Models, A | 2017 |
1 other study available for pioglitazone and Urinary Lithiasis
| Article | Year |
|---|---|
Pioglitazone decreased renal calcium oxalate crystal formation by suppressing M1 macrophage polarization via the PPAR-γ-miR-23 axis.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Binding Sites; Calcium Oxalate; Crystallization; Disea | 2019 |